
Kontour Medical released its semi-annual performance, with a net profit attributable to the parent company of 54.9986 million yuan, a year-on-year increase of 12.72%

According to the Zhitong Finance APP, Kontour Medical disclosed its semi-annual report for 2025. During the reporting period, the company achieved revenue of 170 million yuan, a year-on-year increase of 11.07%; net profit attributable to shareholders was 54.9986 million yuan, a year-on-year increase of 12.72%; net profit excluding non-recurring items was 50.3874 million yuan, a year-on-year increase of 25.02%; basic earnings per share were 0.68 yuan. The company plans to distribute a cash dividend of 2 yuan (including tax) for every 10 shares to all shareholders
According to the Zhitong Finance APP, Kontour Medical (688314.SH) disclosed its semi-annual report for 2025. During the reporting period, the company achieved revenue of 170 million yuan, a year-on-year increase of 11.07%; net profit attributable to shareholders was 54.9986 million yuan, a year-on-year increase of 12.72%; net profit excluding non-recurring items was 50.3874 million yuan, a year-on-year increase of 25.02%; basic earnings per share were 0.68 yuan. The company plans to distribute a cash dividend of 2 yuan (tax included) for every 10 shares to all shareholders

